A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
Issue Date
2020-07-17Keywords
GENERAL PRACTICECOVID-19
OAT
Opioid agonist therapy
Opioid user
Remote health
TELEMEDICINE
Metadata
Show full item recordJournal
Harm reduction journalDOI
10.1186/s12954-020-00394-zPubMed ID
32680520Item Type
ArticleLanguage
enEISSN
1477-7517ae974a485f413a2113503eed53cd6c53
10.1186/s12954-020-00394-z
Scopus Count
Collections
Related articles
- Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland.
- Authors: Van Hout MC, Crowley D, McBride A, Delargy I
- Issue date: 2018 Jun 30
- Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
- Authors: Cochran G, Bruneau J, Cox N, Gordon AJ
- Issue date: 2020
- Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery.
- Authors: Høj SB, de Montigny C, Chougar S, Léandre R, Beauchemin-Nadeau MÈ, Boyer-Legault G, Goyette A, Lamont SK, Bruneau J
- Issue date: 2023 Jul 26
- Opioids: The Forgotten Epidemic?
- Authors: Price S
- Issue date: 2020 Oct 1
- Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports.
- Authors: Crowley D, Homeniuk R, Delargy I
- Issue date: 2020 Dec 4